Invezz is an independent platform with the goal of helping users achieve financial freedom. In order to fund our work, we partner with advertisers who compensate us for users that Invezz refers to their services. While our reviews and assessments of each product on the site are independent and unbiased, brands may pay to appear higher up our table rankings or place ads in specific areas of the site. The order in which products and services appear on Invezz does not represent an endorsement from us, and please be aware that there may be other platforms available to you than the products and services that appear on our website. Read more about how we make money >
Lucira Health Inc (NASDAQ:LHDX)
|Dividend Rate (ttm)||0.0000|
|Trading Day||Jan 25|
|Day's Range||4.62 - 5.06|
|52 Week Range||4.23 - 37.99|
Lucira Health Inc dividends
Lucira Health Inc has a market cap or net worth of $194.16 million. The enterprise value is $0.
Lucira Health Inc has 39.22 million shares outstanding.
The trailing PE ratio is 0.0000 and the forward PE ratio is -5.6180. Lucira Health Inc's PEG ratio is 0.0000.
Stock Price Statistics
The stock price has decreased by -0.4193%. The beta is 0.0000, so Lucira Health Inc's price volatility has been lower than the market average.
In the last 12 months, Lucira Health Inc had revenue of $0 and earned $0 in profits. Earnings per share was $.
Lucira Health is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira has developed a testing platform that produces centralized-laboratory-accurate molecular testing in a single-use and consumer-friendly test kit that is powered by two AA batteries and fits in the palm of a hand.
Lucira designed its test kits to provide accurate, reliable and on-the-spot molecular test results anywhere and at any time. The LUCIRA COVID19 All-In-One Test Kit is designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection..